Advertisement
Quoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003
(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX) announced Monday that the U.S. Food and Drug Administration (FDA) has cleared the recruitment of teen subjects aged 14 years and older into its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome (NS).
Both trials are being conducted under Quoin's open Investigational New Drug Application (IND) for QRX003. The clearance includes teen patients in both the company's open label and placebo controlled studies.
This important development represents the first ever inclusion of non-adult subjects in Netherton Syndrome clinical studies conducted under an open Investigational New Drug Application.
read more
Switzerland Logs Weaker Growth, Trims 2026 Outlook
The Swiss economy expanded modestly in the second quarter, as estimated earlier, and higher U.S. tariffs are set to push down growth prospects, the State Secretariat for Economic Affairs said Thursday. Gross domestic product grew 0.1 percent from the first quarter, unchanged from the flash estimate. Growth softened notably from 0.7 percent in the first quarter.
RTTNews
|
43分钟前
U.S. GDP Jumps More Than Previously Estimated In Q2
The U.S. economy grew by more than previously estimated in the second quarter of 2025, according to revised data released by the Commerce Department on Thursday.
RTTNews
|
51分钟前
U.S. Weekly Jobless Claims Edge Down To 229,000
A report released by the Labor Department on Thursday showed a modest decrease by first-time claims for U.S. unemployment benefits in the week ended August 23rd.
RTTNews
|
56分钟前
FTSE 100 Down 0.4% In Cautious Trade
After a slightly positive start, U.K. stocks turned weak Thursday morning with investors treading cautiously amid a lack of triggers. Shares of financials and utilities companies are struggling a bit.
RTTNews
|
2小时7分钟前
CAC Up Slightly; Pernod Ricard Rises On Earnings
The French market is up slightly a little past noon on Thursday, supported by data showing an increase in new car registrations in Europe, and stronger-than-expected results and forecast from AI chip major Nvidia.
RTTNews
|
2小时26分钟前
DAX Retreats After Firm Start, Down Marginally
After opening on a strong note thanks to easing AI slowdown fears after Nvidia's impressive results, the German market retreated and slipped into negative territory on Thursday. Despite paring some early gains, auto stocks remain fairly well up in positive territory.
RTTNews
|
2小时49分钟前
Swiss Franc Rises Against Majors
The Swiss franc strengthened against other major currencies in the European session on Thursday.
RTTNews
|
3小时5分钟前
Sensex, Nifty Retreat On US Tariff Worries
Indian shares fell sharply on Thursday as traders waited to see how New Delhi responds to pressure from Washington to stop buying Russian oil after the 50 percent tariffs levied by the U.S. on Indian goods came into effect on Wednesday.
RTTNews
|
3小时10分钟前
